ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 223 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2021. The put-call ratio across all filers is 2.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $473 | +4.2% | 35,978 | 0.0% | 0.01% | +25.0% |
Q2 2023 | $454 | +2.3% | 35,978 | +5.7% | 0.00% | 0.0% |
Q1 2023 | $444 | -26.0% | 34,032 | 0.0% | 0.00% | -33.3% |
Q4 2022 | $600 | -99.9% | 34,032 | -19.1% | 0.01% | -25.0% |
Q3 2022 | $641,000 | -33.2% | 42,092 | -1.2% | 0.01% | -11.1% |
Q1 2022 | $959,000 | +22.0% | 42,590 | 0.0% | 0.01% | +28.6% |
Q4 2021 | $786,000 | +38.1% | 42,590 | 0.0% | 0.01% | +40.0% |
Q3 2021 | $569,000 | -27.8% | 42,590 | 0.0% | 0.01% | -28.6% |
Q2 2021 | $788,000 | +23.3% | 42,590 | 0.0% | 0.01% | +16.7% |
Q1 2021 | $639,000 | +14.7% | 42,590 | +10.4% | 0.01% | 0.0% |
Q4 2020 | $557,000 | +132.1% | 38,590 | +30.9% | 0.01% | +100.0% |
Q3 2020 | $240,000 | +27.0% | 29,476 | +5.5% | 0.00% | +50.0% |
Q2 2020 | $189,000 | +11.8% | 27,946 | +16.7% | 0.00% | 0.0% |
Q1 2020 | $169,000 | -28.1% | 23,946 | 0.0% | 0.00% | -33.3% |
Q4 2019 | $235,000 | -10.6% | 23,946 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $263,000 | -17.6% | 23,946 | -12.8% | 0.00% | -25.0% |
Q2 2019 | $319,000 | +21.8% | 27,446 | 0.0% | 0.00% | +33.3% |
Q1 2019 | $262,000 | -10.6% | 27,446 | -9.6% | 0.00% | -25.0% |
Q4 2018 | $293,000 | -32.2% | 30,346 | 0.0% | 0.00% | -20.0% |
Q3 2018 | $432,000 | +10.2% | 30,346 | -7.0% | 0.01% | 0.0% |
Q2 2018 | $392,000 | -2.7% | 32,646 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $403,000 | -20.5% | 32,646 | -6.2% | 0.01% | -16.7% |
Q4 2017 | $507,000 | +2.4% | 34,820 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $495,000 | +11.5% | 34,820 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $444,000 | -7.5% | 34,820 | -7.9% | 0.01% | 0.0% |
Q1 2017 | $480,000 | +4.6% | 37,820 | -16.0% | 0.01% | 0.0% |
Q4 2016 | $459,000 | -13.6% | 45,000 | +11.7% | 0.01% | -14.3% |
Q3 2016 | $531,000 | +3.7% | 40,300 | 0.0% | 0.01% | 0.0% |
Q2 2016 | $512,000 | -3.8% | 40,300 | 0.0% | 0.01% | 0.0% |
Q1 2016 | $532,000 | +7.5% | 40,300 | +25.2% | 0.01% | +16.7% |
Q4 2015 | $495,000 | +24.1% | 32,200 | 0.0% | 0.01% | +20.0% |
Q3 2015 | $399,000 | -9.3% | 32,200 | 0.0% | 0.01% | 0.0% |
Q2 2015 | $440,000 | +14.3% | 32,200 | 0.0% | 0.01% | +25.0% |
Q1 2015 | $385,000 | -6.3% | 32,200 | 0.0% | 0.00% | -20.0% |
Q4 2014 | $411,000 | -4.9% | 32,200 | 0.0% | 0.01% | 0.0% |
Q3 2014 | $432,000 | -16.4% | 32,200 | 0.0% | 0.01% | -16.7% |
Q2 2014 | $517,000 | -82.2% | 32,200 | -80.0% | 0.01% | -82.4% |
Q1 2014 | $2,902,000 | -23.0% | 160,950 | -33.9% | 0.03% | -22.7% |
Q4 2013 | $3,767,000 | -8.5% | 243,650 | -12.0% | 0.04% | +15.8% |
Q3 2013 | $4,116,000 | +13.4% | 276,790 | -1.3% | 0.04% | +11.8% |
Q2 2013 | $3,629,000 | – | 280,430 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |